The market opportunity for specialty data analytics is significant and growing. Data analytics tools that integrate, aggregate, and apply analyzed insights on specialty pharmaceutical data on an immense scale help identify and understand historical data patterns and may predict future events. Data analytics is growing as it helps industry stakeholders observe regulatory requirements while helping to reduce costs and improve quality of care.
The ongoing rapid growth in specialty drug spending has increased the need for data and analytic tools in the specialty market. Specialty pharmacies and HUB providers are uniquely positioned to collect data on patients, prescribers, and payers as well as utilization data.
AMI’s report, Specialty Data Analytics Overview, identifies and provides comprehensive intelligence on the growing number of companies offering analytic tools and services in the specialty data market. The report, 135 pages, also provides a brief background on the market. Each specialty data analytics provider profile includes: company background, corporate strategy, top executives, financial/investor information, products and services, and recent activities.
Table of Contents
Introduction
- Specialty Pharmaceuticals Background – pgs. 5-6
Company Profiles
- Accenture Life Sciences – pgs. 7-9
- AmerisourceBergen/Lash Group/IntrinsiQ – pgs. 10-12
- Amplity Health – pgs. 13-15
- Asembia – pgs. 16-17
- AssistRx – pgs. 18-19
- Axtria, Inc. – pgs. 20-22
- BetaXAnalytics – pgs. 23-24
- Capgemini Invent – pgs. 25-27
- Cardinal Health Specialty Solutions – pgs. 28-29
- CareMetx, LLC – pgs. 30-32
- Clarify Health – pgs. 33-35
- Claritas Rx – pgs. 36-37
- ConcertAI Patient Solutions – pgs. 38-40
- Datavant p pgs. 41-43
- Deloitte – pgs. 44-46
- eMAX Health Systems, LLC – pgs. 47-48
- EVERSANA – pgs. 49-52
- First Databank, – pgs. 53-54
- Health Data & Management Solutions – pgs. 55-56
- HealthConnexx LLC – pgs. 57-58
- Helio Health Group – pgs. 59-60
- Indegene – pgs. 61-62
- Infowerks – pgs. 63-64
- Inovalon – pgs. 65-67
- IntegriChain – pgs. 68-71
- IQVIA – pgs. 72-73
- Loopback Analytics – pgs. 74-75
- Managed Health Care Associates (MHA) – pgs. 76-78
- Management Science Associates (MSA) – pgs. 79-80
- Medidata – pgs. 81-83
- Omnicell/FDS Amplicare – pgs. 84-86
- OptimizeRx – pgs. 87-89
- OptumInsight – pgs. 90-92
- Pharmaceutical Strategies Group/EPIC – pgs. 93-94
- PharmaCord LLC – pgs. 95-97
- Pharmspective – pgs. 98-99
- Precision Value & Health – pgs. 100-102
- Prognos Health – pgs. 103-105
- QPharma, Inc. – pgs. 106-108
- Real Chemistry – pgs. 109-111
- Remedy Analytics – pgs. 112-113
- RxDataScience – pgs. 114-115
- SS&C Health – pgs. 116-118
- Syneos Health – pgs. 119-122
- TrxADE Health, Inc. – pgs. 123-125
- TrialCard Inc. – pgs. 126-128
- Trinity Life Sciences – pgs. 129-131
- Veeva Systems – pgs. 132-134
- Veradigm – pgs. 135-136